Dr. Kumar’s Take:
This is a narrative review of low-level laser (light) therapy (LLLT) for hair loss, not a single clinical trial, and the evidence behind it mixes animal work with controlled human studies. The authors conclude that LLLT for hair growth in both men and women appears to be both safe and effective, while the optimum wavelength, coherence and dosimetric parameters remain to be determined. That is roughly where I place it in practice: a reasonable non-drug option for androgenetic alopecia, with the caveat that nobody yet knows the right dose or the right light. Minoxidil and finasteride are still the only two approved drugs, and hair transplantation remains the other established alternative.
Brief Summary:
The authors searched PubMed and Google Scholar for alopecia, hair loss, LLLT and photobiomodulation, then surveyed the evidence for low-level laser therapy applied to the scalp and discussed the possible mechanisms. Alopecia affects more than half of the population worldwide. Androgenetic alopecia, the most common type, affects 50% of males over the age of 40 and 75% of females over 65. The most commonly used LLLT devices emit wavelengths in the range of 500 to 1,100 nm, the so-called optical window of tissue, delivering fluences of 1 to 10 J/cm² at power densities of 3 to 90 mW/cm². The main proposed mechanism is stimulation of epidermal stem cells in the hair follicle bulge, shifting follicles into the anagen phase.
Key Takeaways:
✔ This is a review of the LLLT literature, not a new trial.
✔ LLLT stimulated hair growth in mice with chemotherapy-induced alopecia and in alopecia areata.
✔ Controlled clinical trials demonstrated that LLLT stimulated hair growth in both men and women.
✔ The hypothesized main mechanism is stimulation of epidermal stem cells in the follicle bulge, moving follicles into anagen.
✔ The HairMax LaserComb received FDA 510(k) clearance as a safe therapy for male androgenetic alopecia in 2007 and female androgenetic alopecia in 2011.
Study Design:
This is a review article. The authors carried out searches of PubMed and Google Scholar using the keywords alopecia, hair loss, LLLT and photobiomodulation, then surveyed the resulting evidence for low-level laser therapy applied to the scalp as a treatment for hair loss and discussed possible mechanisms of action. The evidence surveyed includes animal work and controlled clinical trials rather than a single pooled dataset, so there is no common treatment protocol or shared endpoint across the studies reviewed.
Results:
✔ LLLT stimulated hair growth in mice subjected to chemotherapy-induced alopecia.
✔ LLLT stimulated hair growth in alopecia areata.
✔ Controlled clinical trials showed hair growth in both men and women.
✔ The authors conclude LLLT for hair growth appears both safe and effective.
✔ The optimum wavelength, coherence and dosimetric parameters remain to be determined.
How Red Light Therapy Works for Hair Growth:
Red and near-infrared light has long been known to promote tissue repair and regeneration, and low-intensity light stimulates cellular activity. Applied to the scalp, the proposed mechanism runs through the hair cycle itself:
- Hair follicles cycle through anagen (rapid growth), catagen (apoptosis-driven regression) and telogen (resting).
- Bulge stem cells sit in the outer root sheath just below the sebaceous gland, at the anchorage point of the arrector pili muscle.
- During the telogen to anagen transition, these epithelial bulge stem cells are activated in a tightly controlled way, and secondary hair germ cells give rise to transient amplifying progeny.
- The main hypothesized mechanism of LLLT is stimulation of those epidermal stem cells in the bulge, shifting follicles into anagen.
- In androgenetic alopecia, abnormal androgen signaling disrupts progenitor cell activation and transient amplifying cell proliferation, miniaturizing terminal follicles into vellus follicles.
Beyond the scalp, LLLT has shown beneficial effects in wound healing, nerve regeneration, joint pain relief, stroke recovery, and the prevention and treatment of mucositis.
Related Studies and Research
Low-level light therapy is one of several innovative approaches for androgenetic alopecia. For a broader perspective, explore:
- Androgenetic Alopecia Treatments: A Comprehensive Review: An in-depth look at all major treatment options.
- Microneedling and Hair Regrowth: A Synergistic Approach: How microneedling may enhance the effects of light therapy.
- Minoxidil, Finasteride, and Dutasteride: Pharmacological Interventions: A comparison of the most researched pharmaceutical treatments.
- Saw Palmetto and Hair Growth: Can Natural DHT Blockers Work?: Exploring plant-based alternatives to pharmaceutical interventions.
Frequently Asked Questions:
What wavelength and dose does LLLT use?
The most commonly used devices fall in the 500 to 1,100 nm range and deliver fluences of 1 to 10 J/cm² at power densities of 3 to 90 mW/cm². The authors are explicit that the optimum wavelength, coherence and dosimetric parameters for hair growth have yet to be established.
Is LLLT safe?
The review concludes that LLLT for hair growth in both men and women appears to be both safe and effective. The HairMax LaserComb was cleared by the FDA as a safe therapy for male androgenetic alopecia in 2007 and for female androgenetic alopecia in 2011.
Can women use LLLT for hair loss?
Yes. Controlled clinical trials demonstrated that LLLT stimulated hair growth in both men and women, and the device clearance covers female androgenetic alopecia.
How does LLLT compare to prescription treatments?
Only two drugs have been approved for androgenetic alopecia, minoxidil and finasteride, with hair transplantation as the other alternative. Current therapies are not efficacious for all patients: medical therapy requires indefinite use and is limited by adherence, while surgery is limited by cost, the patient’s supply of donor hair, and possible scarring at donor sites. LLLT emerged as a newer therapeutic approach against that backdrop.
Conclusion:
Low-level laser therapy is a reasonable non-invasive option for androgenetic alopecia. The review finds it appears both safe and effective for hair growth in men and women, with stimulation of epidermal stem cells in the follicle bulge and a shift into anagen as the leading proposed mechanism. The honest limitation is dosimetry: the optimum wavelength, coherence and light dose are still unsettled, which is why I treat LLLT as a complement to established options rather than a replacement for them.
